| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SL 0101-1 | GDSC1000 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | SZ4TA2 | CTRPv2 | pan-cancer | AAC | 0.056 | 0.4 |
| mRNA | Compound 23 citrate | CTRPv2 | pan-cancer | AAC | -0.033 | 0.4 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | -0.049 | 0.4 |
| mRNA | Ko-143 | CTRPv2 | pan-cancer | AAC | -0.036 | 0.4 |
| mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | -0.05 | 0.4 |
| mRNA | shikonin | GDSC1000 | pan-cancer | AAC | -0.031 | 0.4 |
| mRNA | LY-2157299 | CTRPv2 | pan-cancer | AAC | 0.076 | 0.4 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.039 | 0.4 |